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The murine blastocyst contains two nonoverlapping pools of progenitor cells: the embryonic component contributes to the fetus and
generates embryonic stem cells in vitro, whereas the extraembryonic pool contributes to the placenta and generates trophoblast stem cells in
vitro. The transcriptional repressor Foxd3 is required for maintenance of the epiblast and the in vitro establishment of embryonic stem cell
lines. Here, we demonstrate that Foxd3 is also required in the trophoblast lineage. Trophoblast progenitors in Foxd3/ embryos do not self-
renew and are not multipotent, but instead give rise to an excess of trophoblast giant cells. Injection of Foxd3/ blastocysts with wild type
ES cells fails to rescue Foxd3/ placentas and such chimeras die around 10 days of embryogenesis. These results indicate an essential role
for Foxd3 in two nonoverlapping progenitor cell populations that require different secreted factors to maintain their multipotent properties in
vitro and give rise to divergent tissues in vivo. Moreover, this provides support for the hypothesis that there are conserved molecular
mechanisms for maintaining the self-renewing properties of diverse progenitor cell types.
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Progenitor cells from different tissues and stages of
development have the shared property that they must
undergo cell division to repopulate their numbers while
retaining the ability to generate multiple differentiated
tissues. Exhaustion of the progenitor pool is incompatible
with either the successful gestation of the embryo or
homeostasis of the adult organism. It has been suggested
that stem cells from diverse lineages share common
molecular mechanisms to maintain their self-renewal
properties (Ivanova et al., 2002; Ramalho-Santos et al.,
2002; Tanaka et al., 2002). However, to date, there has been0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(Evsikov and Solter, 2003; Fortunel et al., 2003).
The murine preimplantation embryo contains two non-
overlapping pools of progenitor cells with the ability to
give rise to multipotent stem cell lines in vitro. The inner
cell mass (ICM) of the 3.5 days post coitum (dpc)
blastocyst develops into the epiblast that gives rise to all
the cells of the embryo proper. Cells of the ICM can be
cultured to generate pluripotent embryonic stem cells (ES
cells), and epiblast cells of the 6.5 dpc embryo can give rise
to teratocarcinomas containing pluripotent stem cells. The
complementary population of progenitors, the polar tro-
phectoderm of the blastocyst (the trophectoderm cells in
direct contact with the ICM), develops into the extraem-
bryonic ectoderm (ExE) and ectoplacental cone (EPC).
These cells give rise to most of the fetal components of the
placenta in vivo and are capable of generating trophoblast
stem cell (TS cell) lines in vitro. ES and TS cells not only
derive from these two different pools of progenitor cells,85 (2005) 126 – 137
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overlapping. When injected into a blastocyst, ES cells can
contribute to all cells of the embryo proper and extraem-
bryonic mesoderm but not to the trophoblast lineage
(Beddington and Robertson, 1989). In contrast, TS cells
contribute to the ExE, EPC and trophoblast giant cells but
are not observed in the embryo proper or in ICM-derived
extraembryonic mesoderm (Tanaka et al., 1998). Finally,
the growth factor requirements for these two stem cell
pools are distinct. Pluripotent ES cells require either Bmp4
or ligands such as LIF that signal through the gp130
receptor and activate the Stat3 pathway, while TS cells are
dependent on Fgf4 and the Tgfh related molecules Activin
and/or Nodal supplied by feeder cells (Erlebacher et al.,
2004; Guzman-Ayala et al., 2004; Kunath et al., 2004; Qi et
al., 2004; Ying et al., 2003).
We have previously identified Foxd3 as a gene required
for maintenance of the ICM and the subsequent establish-
ment of ES cells (Hanna et al., 2002). Foxd3/ embryos
die around 6.0 dpc with a loss of pluripotent epiblast and
an expansion of the proximal ExE. In vivo, the Foxd3/
ExE differentiates almost exclusively into trophoblast giant
cells, suggesting defects in the maintenance of the
trophoblast progenitor cells. Supporting this finding, we
show here that it has not been possible to establish TS cell
lines from Foxd3/ 3.5 dpc blastocysts or 6.5 dpc ExE.
Injection of wild type ES cells into Foxd3/ blastocysts
rescues the mutant epiblast to approximately 9.5 dpc.
However, examination of the extraembryonic compartment
of these chimeras reveals that the placentas do not contain
normally differentiated spongiotrophoblast or labyrinthine
cell layers. Therefore, the chimeric placentas do not
undergo branching morphogenesis and do not support
survival past 9.5 dpc. The identification of a molecule
required for two such diverse stem cell populations is an
important step towards understanding the molecular basis
of the maintenance of progenitor cells in vivo and of stem
cells in vitro.Materials and methods
Mice
Mice used for this work were previously described (Hanna
et al., 2002) and were maintained on an outbred CD-1 back-
ground (Charles River Laboratories). We used two mutant
null alleles for all studies, Foxd3tm1Lby and Foxd3tm2Lby, and
results were consistent with each.
Histology
Histology was performed using standard techniques
(Presnell and Schreibman, 1997). Embryos were dissected
free from the uterus in PBS with 0.1%BSA and whole
decidua fixed in Bouin’s for immunohistochemistry or 4%paraformaldehyde/PBS for in situ hybridization. Tissue was
dehydrated, cleared in Xylenes, embedded in Paraplast+
and 6 to 10 Am paraffin sections cut for staining. Three
different Foxd3 antisera were used. Two affinity-purified
Foxd3 antisera were produced by Washington Biotechnol-
ogy, Inc. The first was generated against the peptide
GEGDEALDKDSECEST from the more N-terminal por-
tion of the protein (AA 29–44). This antiserum was
intended to be specific to Xenopus Foxd3 but crossreacts
with murine Foxd3. The second peptide used was
DVVGEGDDGLEEKDSDAG (AA 26–43). This antise-
rum was used for the bulk of the experiments presented
here. Recently, we have used an antiserum commercially
available from Chemicon and obtained similar results.
Placental lactogen 1 (Plac1, also known as Csh1) antiserum
was a gift from Dr. Frank Talamantes. All primary antisera
were used at a dilution of 1:1000. Antigen retrieval was
performed for the Foxd3 antiserum using Antigen Unmask-
ing Solution (Vector Laboratories) by incubating at 95
degrees for 45 min followed by an extended return to room
temperature (at least 30 min). Primary antibodies were
detected using Vectastain ABC kit (Vector Laboratories). In
situ hybridization was performed as described by Mill et al.
(2003). Digoxigenin labeled RNA probes were prepared
using reagents from Roche Molecular Biochemicals, signal
was developed for 3 h to 2 days and sections counter-
stained with eosin. For in situ hybridizations and Csh1/
Plac1 immunohistochemistry, multiple embryos were pre-
pared in the same blocks and at least two full litters (n = 4
mutant and 10 normal embryos) were examined for marker
expression. The genotype of the embryos was inferred
based on the well characterized histological phenotype of
Foxd3/ embryos.
Trophoblast stem cell derivation and culture
Embryos were isolated from timed Foxd3+/ 
Foxd3+/ matings at either 3.5 dpc (blastocyst stage) or
6.5 dpc. Either the entire blastocyst or the isolated ExE was
plated onto mitotically inactivated primary embryonic
feeder cells as described by Tanaka et al. (1998). Briefly,
culture medium consisted of RPMI 1640 supplemented with
20% fetal bovine serum (Summit Biotechnology), 50 Ag/ml
each pen/strep, 1 mM sodium pyruvate, 100 AM h-
mercaptoethanol (Sigma), 2 mM l-glutamine, 25 ng/ml
Fgf4 (Sigma) and 1 Ag/ml heparin (Sigma). All reagents
were obtained from Gibco-Invitrogen unless otherwise
indicated. Outgrowths were disaggregated after 4 days with
0.25% trypsin/EDTA, plated onto new feeder plates and
lines were established. Cell morphology of each line was
photographed at regular intervals. To genotype cell lines,
they were cultured without feeders for at least three passages
while supplemented with 70% feeder-conditioned medium.
Cells were harvested and DNA extracted for analysis. Lines
were genotyped by Southern blot as described previously
(Hanna et al., 2002).
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Chimeras were generated by injection of Rosa26.1 ES
cells (5–15 cells) into blastocysts isolated from Foxd3+/
intercrosses and transferred to pseudo-pregnant females (2.5
dpc) to continue gestation. Embryos were dissected between
9.5 and 12.5 dpc and each conceptus was divided into three
samples: (1) embryos were stained with Xgal using standard
techniques (Nagy et al., 2003); (2) placentas were fixed in
4% paraformaldehyde for histology and (3) yolk sacs were
protease-treated to separate the extraembryonic mesoderm
from the extraembryonic endoderm (Nagy et al., 2003).
DNA was extracted from extraembryonic endoderm to
genotype the host blastocyst retrospectively.Results
Foxd3 expression in the gastrula stage mouse embryo
Foxd3 is expressed in the preimplantation mouse
embryo and in both mouse and human ES cells (Hanna
et al., 2002; Pera et al., 2000; Sutton et al., 1996).
Mutational analysis has demonstrated that the protein is
required for maintenance of the ICM-derived epiblast and
the establishment of murine ES cell lines (Hanna et al.,
2002). Foxd3 is expressed throughout the epiblast at 6.5
dpc (Fig. 1A) and the protein is primarily nuclear. In
addition, two extraembryonic cell types express Foxd3 at
somewhat lower levels than epiblast cells; we consistently
observed scattered ExE cells expressing nuclear Foxd3 at
higher levels than their neighbors (arrows in Fig. 1B, n = 6
embryos) and primary trophoblast giant cells (arrow in Fig.
1C, n = 6 embryos). Immunolocalization of Foxd3 protein
agrees with previous localization of the mRNA in the
epiblast at 6.5 dpc and neural crest cells at 8.5 dpc and later
(Fig. 1D; Hanna et al., 2002; Labosky and Kaestner, 1998).
In addition, the faint ExE expression agrees with our
previous RT-PCR analysis demonstrating that Foxd3
mRNA was detected in the extraembryonic region (Hanna
et al., 2002). As an additional control for the immunoloc-
alization, no expression of the protein is observed in
Foxd3/ embryos (Fig. 1E). At 8.5 dpc, expression of
Foxd3 in the trophoblast lineage is restricted to scattered
secondary giant cells at the periphery of the developing
placenta (Figs. 1F and G); this expression is gradually
downregulated and Foxd3 is not detected in mature giant
cells later in development. Expression of Foxd3 is not
detected in other embryonic lineages at 8.0 dpc (data not
shown), but is reinitiated in multipotent neural crest cells
(Fig. 1D), cells in the spinal cord and other regions of the
embryo and adult (Dottori et al., 2001; Labosky and
Kaestner, 1998, and data not shown). Undifferentiated ES
cells and several tumor cell lines (Tera1, P19, N-Tera-2D1,
A33 and 1618 embryonal carcinoma cells) express high
levels of Foxd3 and this expression is downregulated as thecells are induced to differentiate (Sutton et al., 1996).
Immunocytology revealed that the Foxd3 is also expressed
in TS cells. The protein is restricted to the nucleus in
undifferentiated TS cells (Fig. 1H), and when TS cells are
differentiated in response to the removal of Fgf4 and feeder
cell conditioned medium, Foxd3 expression is gradually
downregulated in giant cells (arrows in Fig. 1I), but
retained in the smaller cells, presumably undifferentiated
TS cells, remaining in the culture (arrowheads in Fig. 1I).
Loss of Foxd3 causes extraembryonic patterning defects
The development of embryonic and extraembryonic
tissues is intimately linked and each is dependent upon
signals emanating from one tissue to the other. Foxd3/
embryos show a loss of epiblast tissues by 6.5 dpc and a
concomitant increase in ExE as indicated by the expanded
expression of Errb, Bmp8B and Fgfr2 (Hanna et al., 2002).
Therefore, we examined the fate of this separate yet
interdependent lineage. The mammalian placenta connects
the developing embryo to the maternal blood and nutrient
supply through a vascular network. This organ consists
primarily of three different cell types: trophoblast giant
cells, identified by their polyploid nuclei and synthesis of
chorionic somatomammotropin (Csh1, previously termed
Placental lactogen 1); spongiotrophoblast cells, identified
by the transcription of Trophoblast-specific binding protein
a (Tpbpa, previously known as 4311) and labyrinthine cells,
identified by transcription of Tfeb (see Rossant and Cross,
2001 for review). Trophoblast giant cells and the spongio-
trophoblast layers are derived exclusively from the polar
trophectoderm and ExE whereas the labyrinthine layer is
comprised of cells from both trophectoderm and ICM-
derived extraembryonic mesoderm. At 8.5 dpc, the mature
placenta is not yet developed but Csh1, Tpbpa and Tfeb are
expressed by trophoblast giant cells, spongiotrophoblast
precursor cells and labyrinthine precursor cells, respec-
tively. We examined the expression of these three lineage
specific markers in histological sections of Foxd3+/+ or +/
and / 8.5 dpc embryos, using a combination of immuno-
histochemistry and in situ hybridization. Foxd3/
embryos were identified by their morphology. Hematoxylin
and eosin staining of sections of normal embryos (Foxd3+/+
or +/) and Foxd3/ littermates revealed that Foxd3/
embryos initiated a decidual reaction in the uterine stroma
and produced giant cells and a small amount of trophoblast
tissue. Expression of Csh1 showed an excess of tropho-
blast giant cells as compared to normal littermates (Figs.
2E–H). In contrast, we detected no Tpbpa transcription,
indicating a loss of the spongiotrophoblast lineage in
Foxd3/ embryos (Figs. 2I–L), and no evidence for
labyrinthine precursors as shown by the absence of Tfeb
mRNA (Figs. 2M–P).
These lineage-specific markers indicated a shift in the
fate of the mutant trophoblast progenitor cell pool towards
giant cells without development of the spongiotrophoblast
Fig. 1. Expression of Foxd3 in the early embryo. (A) At 6.5 dpc, expression of Foxd3 protein is detected in nuclei of all the cells of the epiblast. Rectangles in
panel A indicate the fields magnified in panels B and C as labeled. (B, C) Foxd3 protein is enriched in some cells in the extraembryonic ectoderm (arrows in
panel B) and in trophoblast giant cells (arrow in panel C). (D, E) To characterize the antiserum more thoroughly, Foxd3 protein is detected in the dorsal most part
of the neural tube and neural crest cells emigrating from the neural tube (arrows) at 9.5 dpc and is not detected in Foxd3/ mutant embryos at 6.5 dpc. (F, G)
At 8.5 dpc, Foxd3 is detected in some secondary giant cells at the edge of the developing placenta. The border of the placenta is indicated with a dashed red line
in panel F. The rectangle in panel F indicates the field magnified in panel G as labeled. Note the pair of giant cells indicated by arrows in panel G, the rightmost
cells (marked with a ‘‘+’’) are expressing nuclear Foxd3 while the one on the left (marked with a ‘‘’’) is not. (H) A colony of multipotent TS cells expressing
Foxd3 is shown in the middle of the field surrounded by neighboring feeder cells that are not expressing Foxd3. (I) When Fgf4 and feeder cell conditioned
medium are removed from the culture, TS cells differentiate into giant cells (arrows). Foxd3 expression is reduced in the giant cells and maintained in the
smaller stem cells remaining in the culture (arrowheads). Panels H and I are the same magnification; note that the nuclei of the stem cells in panel H are the same
size as those indicated by arrowheads in panel I. Abbreviations: Ep, epiblast; ExE, extraembryonic ectoderm; GC, trophoblast giant cell; NC, neural crest.
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sion of early molecular determinants of the trophoblast
lineage. The caudal homeobox gene Cdx2 is not required for
ES cell establishment but is required in the trophoblast stem
cell pool (Chawengsaksophak et al., 2004). Cdx2 is
expressed in the posterior region of the embryo at 8.0 dpc
(Fig. 3A, bracket) and in the EPC and chorion at 7.5 and 8.0
dpc (Fig. 3B, bracket and Beck et al., 1995). There was no
detectable Cdx2 expression in Foxd3/ extraembryoniccells at 8.0 dpc (Figs. 3C and D). Errb, encoding the
estrogen-related-receptor-beta is also required for early
development of the trophoblast lineage. We showed
previously that at early embryonic stages (6.5 dpc)
expression of Errb and several other ExE markers (Fgfr2
and Bmp8b) is expanded distally in the ExE of Foxd3/
embryos (Hanna et al., 2002), and here we demonstrate that
Errb expression is not maintained and Errb mRNA is not
detected in Foxd3/ ExE at 8.0 dpc (Figs. 3G and H),
Fig. 2. Molecular analysis of trophoblast lineages present in Foxd3/ extraembryonic tissues. (A–D) Hematoxylin and eosin stained sections of littermates
that are either normal appearing (A, B) or display the Foxd3/ phenotype (C, D). Low magnification fields are shown to illustrate the overall morphology of
the conceptus. Rectangles in each low magnification view indicate the field magnified in the panel immediately to the right. Embryos that appeared identical to
wild type are Foxd3+/+ or +/. (E–H) Neighboring sections processed for immunohistochemistry with a Csh1 (Placental lactogen-1) antiserum to detect
trophoblast giant cells. Arrows indicate Csh1+ cells in brown. Note the relative abundance of these cells in the Foxd3/ embryos in panels G and H
compared to the normal embryo in panels E and F. (I–L) Nonradioactive in situ hybridization of neighboring sections for Tpbpa (4311) mRNA to identify
spongiotrophoblast cells. Positive signal is blue. Spongiotrophoblast is present in a discrete region of the developing placenta in the normal littermate and is not
detected in the Foxd3/ embryo. Arrows indicate positive signal. (M–P) In situ hybridization of neighboring sections for Tfeb mRNA to identify
labyrinthine cells. Arrows indicate positive signal. Tfeb expression is ubiquitous throughout the embryo at 8.5 dpc but limited to the labyrinthine layer of the
developing placenta (M, N). There is no Tfeb mRNA detected in the Foxd3/ mutant placenta (O, P).
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Mash2, a transcription factor of the basic helix–loop–
helix family, is expressed in diploid trophoblast cells prior
to their differentiation and is required for the differ-entiation of spongiotrophoblast cells (Guillemot et al.,
1994). However, there is significant expression of Mash2
mRNA in Foxd3/ extraembryonic lineages at 8.0 dpc
(Figs. 3I–L), suggesting that there are some diploid
Fig. 3. Early molecular determinants of the trophoblast lineage are disrupted in Foxd3/ embryos at 8.0 dpc. Low magnification fields are shown to illustrate
the overall morphology of the conceptus. Blue rectangles in each low magnification view indicate the field shown in the panel to the right. Embryos that
appeared identical to wild type are Foxd3+/+ or +/. (A–D) The homeobox gene Cdx2 is expressed in the posterior of the embryo proper at 8.0 dpc (bracket in
A) and in the ExE (bracket in B) as indicated by the blue colored signal. No Cdx2 mRNA is detected in Foxd3/ tissue (C, D). (E, F) Expression of Errb was
detected in the ExE of Foxd3+/+ or +/ embryos but not in Foxd3/ samples. (I –L)Mash2 mRNA is observed in Foxd3+/+ or +/ ExE (arrows in panel J)
and in the Foxd3/ developing placenta (arrow in panel L), indicating the presence of undifferentiated diploid trophoblast cells. Magnification in panel B is
2 that of panels D, F, H, J and L to best show the Cdx2 mRNA localization. Abbreviation: c, chorion. Arrows indicate expression of mRNAs.
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the mutants; however, Mash2 expression is lost by 9.0 dpc
(data not shown) suggesting that these undifferentiated cells
are short-lived. Together, these data indicate that the early
steps in trophoblast development are initiated with the
expression of ExE genes at 6.5 dpc, but expression of these
key lineage determinants is not maintained normally in the
absence of Foxd3. This suggests that, between 6.5 and 8.0
dpc, most of the trophectoderm cells differentiate into giant
cells and the multipotent progenitor cell population marked
by Cdx2 and Errb mRNAs that would go on to form the
spongiotrophoblast and labyrinthine layers is not maintained.
TS progenitors
Trophoblast stem (TS) cell lines can be derived from 3.5
dpc blastocyst stage embryos and the ExE of embryos prior
to approximately 8.0 dpc (10-somite stage) (Tanaka et al.,
1998; Uy et al., 2002). These stem cell lines are dependent
on Fgf4 and members of the Tgfh family of signaling
molecules, Activin and Nodal (Erlebacher et al., 2004;
Guzman-Ayala et al., 2004; Tanaka et al., 1998). Based onthe initial expansion (at 6.5 dpc) and subsequent loss (at 8.5
dpc) of key ExE lineage proteins required for TS cell
establishment, we reasoned that in the absence of Foxd3
protein there may be defects in the TS progenitor cells.
Supporting this hypothesis, attempts to derive Foxd3/
TS cells have been unsuccessful. We cultured 89 blastocysts
from Foxd3+/  Foxd3+/ crosses and obtained 19
Foxd3+/+ and 28 Foxd3+/ lines (47 total) but no
Foxd3/ cell lines. From 89 blastocysts, we would expect
67 (3/4 of 89) Foxd3+/+ or +/ embryos and 22 Foxd3/.
These data suggest that Foxd3/ TS lines cannot be
established from blastocysts in vitro.
TS cell lines isolated from 3.5 dpc blastocysts are
phenotypically indistinguishable from those isolated from
6.5 dpc ExE (Tanaka et al., 1998). However, they are
transcriptionally distinct and it is not known whether these
differences are important (Tanaka et al., 2002). At 6.5 dpc,
Foxd3/ embryos are morphologically distinguishable
from their littermates. Therefore, we dissected litters from
Foxd3+/  Foxd3+/ crosses at 6.5 dpc and isolated ExE
explants from all identifiable Foxd3/ mutants (n = 18).
These explants were placed into culture along with at least
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or +/) to control for culture conditions. These experiments
resulted in 4 Foxd3+/+ and 11 Foxd3+/ TS cell lines while
none of the 18 Foxd3/ explants gave rise to cell lines.
Together with the results from the blastocyst cultures, these
data demonstrate that the presence of Foxd3 protein is
necessary for the derivation of TS cell lines.
Chimeric rescue of Foxd3/ embryos
Normal development of the placenta and embryo is
dependent upon one another making analysis of Foxd3/
placentas complicated due to loss of the embryo proper. To
address whether the loss of TS progenitor cells in Foxd3/
embryos is a primary defect in the trophoblast lineage or
secondary to the loss of epiblast-derived signals, we
analyzed chimeric embryos and their placentas. We showed
previously that injection of wild type ES cells can rescue
Foxd3/ embryos up to 9.5 dpc (Hanna et al., 2002), but
the requirement for trophoblast-derived placenta is after 9.5
dpc, and embryos with placental defects usually die around
10.5 dpc. Therefore, we examined the placentas of chimeras
at later times of gestation.
We produced chimeras by injecting Rosa26.1 ES cells
into blastocysts isolated from Foxd3+/ intercrosses at 3.5
dpc. Injected blastocysts were transferred to recipient
pseudo-pregnant females and embryos isolated at different
stages of gestation. Chimerism was determined by Xgal
staining since Rosa26.1 ES cells express the beta-galacto-
sidase gene constitutively, and the endoderm of the yolk sac
was used to genotype the recipient embryo retrospectively.
We obtained no rescued Foxd3/ embryos at 12.5 dpc
(out of 11 total chimeras) and only one at 10.5 dpc (out of
46 total chimeras). This lone rescued conceptus contained
an abnormal embryo that was severely developmentally
delayed compared to wild type chimeric littermates (data not
shown). Histological analysis of this single chimeric sample
revealed that the placenta and embryo were much smaller
than normal (data not shown). The placenta contained
trophoblast giant cells but there was no evidence of
branching morphogenesis in the labyrinthine layer.
One hundred ninety-three chimeras were produced and
harvested at 9.5 dpc. Genotyping these chimeras retro-
spectively, we identified 44 Foxd3+/+, 135 Foxd3+/ and
5 Foxd3/ (9 chimeras were not able to be genotyped).
In agreement with our earlier results (Hanna et al., 2002),
four of five rescued Foxd3/ embryos appeared morpho-
logically normal (Figs. 4I–L) and one was developmentally
delayed (Figs. 4E–H). Contribution of wild type ES cells
to the rescued chimeras was very high (Figs. 4E and I).
Histological analysis of the accompanying Foxd3/
placentas showed that they were smaller than normal and
had significant patterning defects that most likely caused
the underrepresentation of Foxd3/ chimeric embryos at
9.5 dpc and the loss of this population 1 day later (Fig. 4).
One of the Foxd3/ placentas had severe vasculardefects resulting in a large blood clot (Figs. 4F–H). This
placenta had a large number of trophoblast giant cells, as
revealed by in situ hybridization for Csh1 mRNA, but no
spongiotrophoblast or labyrinthine cells, as indicated by the
lack of expression of Tpbpa and Tfeb, respectively (Figs.
5D–F). The associated chimeric embryo was developmen-
tally delayed (Fig. 4E) and it would likely have been
resorbed 1 day later at 10.5 dpc. Other Foxd3/
placentas contained spongiotrophoblast and labyrinthine
cells as revealed by in situ hybridization for Tpbpa and
Tfeb mRNAs (Figs. 5G–I), but histological analysis
revealed the presence of a large number of glycogen
trophoblast cells (arrows in Figs. 4K and L indicate the
‘‘foamy’’ appearing glycogen trophoblast cells), a spe-
cialized Tpbpa-expressing spongiotrophoblast cell type
(Cross et al., 2003). In addition to this lack of a mature
spongiotrophoblast cell layer, there were severe vascular
defects indicating that the labyrinth fails to undergo
branching morphogenesis (Figs. 4G, H, K and L).Discussion
Expression of Foxd3 in multiple progenitor populations
One of the challenges facing embryologists and stem cell
biologists is to understand the common and specific
molecular requirements for the maintenance and differ-
entiation of progenitor cells in the embryo and in vitro.
Here, we show that Foxd3 is not only required for the
maintenance of the pluripotent epiblast, and therefore the in
vitro establishment of ES cells, but it is also essential in the
extraembryonic lineage of the mouse embryo. Foxd3 is a
transcriptional repressor expressed in several progenitor cell
populations in the mouse embryo. When first identified, it
was called Genesis based on its expression in murine ES
cells; more recent microarray analysis has shown that
FOXD3 is one of the most highly expressed genes in
human ES and embryonal carcinoma (EC) cells (Sperger et
al., 2003; Sutton et al., 1996). Foxd3 is expressed in the
preimplantation mouse embryo at the blastocyst stage and at
6.5 dpc immunolocalization reveals that the protein is
expressed in the epiblast and scattered cells in the ExE:
progenitors for the embryo proper and the placenta,
respectively. Based on expression of Foxd3 in the blastocyst
and the observation that Foxd3 is only weakly expressed in
the extraembryonic ectoderm at 6.5 dpc, it is likely that the
extraembryonic requirement for Foxd3 is earlier than 6.5
dpc. It is important to note that Foxd3 is not universally
expressed in proliferating cells. For example, at 8.5 dpc, all
embryonic cells are proliferating rapidly but only the neural
crest expresses Foxd3 (Fig. 1D). Foxd3 expression is
maintained in the multipotent neural crest but is down-
regulated as the cells reach their destinations and differ-
entiate (Dottori et al., 2001; Labosky and Kaestner, 1998).
Ectopic expression of Foxd3 in the neural tube can change
Fig. 4. Incomplete rescue of Foxd3/ placentas at 9.5 dpc by wild type ES cells. (A) A 9.5 dpc control chimera generated by injecting Rosa26.1 ES cells into
a Foxd3+/ blastocyst. Blue stain indicates embryonic cells derived from injected ES cells. (B–D) A hematoxylin and eosin stained section of the
corresponding Foxd3+/ placenta. The dashed red line indicates the border of the placenta. Higher magnification shows the developing vasculature; note the
mixing of maternal (enucleated) and fetal (nucleated) red blood cells in panels C and D. Panels E–H and I–L show two chimeras and their associated placentas
generated by injecting wild type ES cells into a Foxd3/ blastocyst. Both placentas have defects in the vasculature; note the large deposit of coagulated blood
in panel F, the absence of maternal blood cells in panel H and the complete loss of any vasculature in panels K and L. Arrows in panels K and L indicate
glycogen trophoblast cells. The embryo associated with the placenta in panels F–H was developmentally delayed, likely due to the disruption of the fetal
circulation that resulted in the large blood clot. Such blood clots were never observed in Foxd3+/+ or +/ chimeric placentas. Yellow rectangles in upper panels
indicate the field enlarged in the panels below.
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Fig. 5. Molecular analysis of chimeric placentas. (A–C) Nonradioactive in situ hybridization was used to assess the lineages present in rescued placentas of
chimeric embryos. A 9.5 dpc Foxd3+/ chimeric placenta (same placenta as Figs. 4B–D) has normal expression of Csh1 (Placental lactogen 1) indicating
giant cells; Tpbpa (4311) indicating spongiotrophoblast and Tfeb indicating labyrinthine cells. (D–F) A morphologically abnormal Foxd3/ rescued
placenta (same placenta as Figs. 4F–H) consists of only giant cells with no mRNA for Tpbpa or Tfeb detected. The large hemorrhage most likely resulted from
the abnormal vasculature. (G– I) A Foxd3/ rescued placenta with contributions to all three cell lineages: Csh1 (Placental lactogen 1) indicating giant cells;
Tpbpa (4311) indicating spongiotrophoblast and Tfeb indicating labyrinthine cells. However, the labyrinth never underwent branching morphogenesis to form
vasculature (Figs. 4J–L) and such placentas and accompanying embryos were not recovered past 9.5 dpc.
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Kos et al., 2001; Sasai et al., 2001). Significantly, when
Foxd3 expression is maintained in these newly generated
neural crest cells, it interferes with their ability to differ-
entiate into neurons suggesting that the cells are maintained
in an uncommitted state (Dottori et al., 2001).
Extraembryonic defects in Foxd3/ embryos
In Foxd3/ mutant embryos, the ICM is established
but not maintained (Hanna et al., 2002). However, this is
only one of the multipotent lineages present in the early
gastrula stage embryo. Cells of the ICM are committed to
the embryonic lineage while the neighboring trophoblast
gives rise to the extraembryonic ectoderm (ExE) and
ectoplacental cone (EPC) that makes up the placenta and
harbors trophoblast progenitor cells. In the absence of
Foxd3, the ExE is initially expanded as indicated by the
expression of genes expressed within and required for TS
cells in vivo and in vitro (Errb, Eomesodermin). Two days
later (8.0 dpc), the expression of such genes (Errb, Cdx2)
is downregulated, the multipotent trophoblast progenitor
pool is not maintained and there is an excess of trophoblastgiant cells with a small number of diploid trophoblast
progenitors (marked by Mash2 expression). These data
support the conclusion that the trophoblast progenitors are
not maintained in a multipotent state, but instead undergo
differentiation into the first trophoblast cell lineage, the
trophoblast giant cells. In addition, there is an over-
abundance of the differentiated trophoblast giant cells in
Foxd3/ embryos at 8.5 dpc when compared to wild type
embryos (Fig. 2). This increase in giant cell number could
be due to the initial ExE expansion at 6.5 dpc indicated by
the distal increase of Errb, Fgfr2 and Bmp8b expression
(Hanna et al., 2002). While it is curious that Errb is first
expanded at 6.5 dpc and then lost at 8.0 dpc, the
similarities in the Foxd3/ and Errb extraembryonic
tissues are striking; a null mutation in Errb results in an
excess of giant cells with no spongiotrophoblast or
labyrinthine trophoblast cell layers formed, and the
embryos die around 10.5 dpc with placental defects (Luo
et al., 1997), so it is possible that the loss of expression of
Errb mRNA at 8.0 dpc (Figs. 3E–H) might account for the
extraembryonic aspect of the Foxd3/ phenotype. Errb
plays no direct role in development of the embryo proper,
suggesting that this receptor is not required for ES cells and
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attempts to derive Errb TS cells were not successful
(Tremblay et al., 2001).
Inability of ES cells to rescue the extraembryonic defects
The mammalian embryo is made up of interacting groups
of cells fated to give rise to diverse tissues. Two populations
of cells, the trophoblast and the ICM, do not intermingle and
illustrate the first lineage restriction in development of the
conceptus (reviewed in Loebel et al., 2003). The devel-
opmental restriction of ICM-derived ES cells that only
contribute to the embryo proper can be used to dissect the
role of different factors in these two tissue types (Bedding-
ton and Robertson, 1989; Tam and Rossant, 2003).
Foxd3/ embryos have profound defects in the epiblast
compartment of the embryo; ES cells cannot be derived
from mutant ICM and teratocarcinomas cannot be generated
by mutant epiblast. However, injection of wild type ES cells
can rescue the embryonic consequences of the loss of Foxd3
until 9.5 dpc after which we observed profound defects in
the extraembryonic compartment of the developing embryo.
Although the chimeras generated (wild type ES cells 6
Foxd3/ blastocyst) have a more normal placenta
compared to unmanipulated Foxd3/ embryos, there is
still an overall failure of development of the labyrinthine
layer and no branching morphogenesis occurred even when
the chimeric embryos were almost completely derived from
wild type ES cells (see for instance Figs. 4I–L), suggesting
that Foxd3 is required intrinsically within the trophoblast
lineage. The observation that chimeric placentas are rescued
to some extent by the presence of Foxd3+/+ cells in the
embryo does suggest that Foxd3/ trophoblast progeni-
tors retain some multilineage potential and can differentiate
into spongiotrophoblast and labyrinthine precursors which
then cannot undergo normal morphogenesis to form a
functional placenta.
Curiously, rescued Foxd3/ chimeras are not reco-
vered in expected numbers. In our earlier report, we
recovered 43 Foxd3+/+, 81 Foxd3+/ and 10 Foxd3/
chimeras and here we report an additional 44 Foxd3+/+, 135
Foxd3+/ and 5 Foxd3/ (totaling 87 Foxd3+/+, 216
Foxd3+/ and 15 Foxd3/). The observation that we
identify any Foxd3/ morphologically normal chimeras at
9.5 dpc supports our previous conclusion that Foxd3 is
required in the epiblast, but there may be specific locations
within the gastrulating embryo that require Foxd3 protein.
The vasculature of the chimeric Foxd3/ placentas was
either grossly abnormal or completely absent at 9.5 and 10.5
dpc indicating a trophoblast defect. The walls of placental
blood vessels are made up of extraembryonic mesodermal
cells, therefore injected wild type ES cells could contribute
to these vessels. Because all of the 5 rescued chimeras in
this study consisted of primarily wild type cells, it is
possible that the presence of these cells in the extraem-
bryonic mesoderm might have allowed those chimeras tosurvive at least until 9.5 dpc. However, instructions from the
trophoblast components of the forming placenta are required
for the labyrinth to undergo branching morphogenesis
resulting in properly patterned vasculature. We detected
both Tpbpa and Tfeb mRNA in chimeric Foxd3/
placentas (Fig. 5). However, these are early markers for
the spongiotrophoblast and labrythine layers and do not
indicate a normally patterned placenta. The histological
analysis clearly indicated the lack of normal differentiation
of these two layers (Fig. 5). Together, these results support
the conclusion that Foxd3 is required in the trophoblast
lineage and that secreted signals from the epiblast cannot
effectively rescue extraembryonic defects caused by the lack
of Foxd3.
Molecular requirements for embryonic and trophoblast stem
cells
The ICM and trophectodermal lineages have the potential
to give rise to multipotent stem cell lines in vitro: ES and TS
cells, respectively. As yet, no shared requirement for sig-
naling molecules has been detected between these lineages.
LIF and other gp130 transduced signals are sufficient to
maintain ES cells in a pluripotent state in vitro and such
signals are required for the murine phenomenon of diapause,
the long-term maintenance of the preimplantation embryo in
the uterus (Nichols et al., 2001; Smith, 2001). Recent work
has shown that Bmp4 is sufficient for the establishment of
ES cell lines (Qi et al., 2004; Ying et al., 2003) and it was
demonstrated previously that Bmpr1a/ embryos have
defects in gastrulation and do not give rise to ES cell lines
(Mishina et al., 1995). Fgf4 is required for early survival of
the blastocyst (Feldman et al., 1995). Fgf4/ ES cells
have defects in survival, but because these cells lines were
established with Fgf4 protein added to the culture medium,
it is not clear whether Fgf4 is required for the initial
establishment of ES cell lines (Wilder et al., 1997).
However, the combination of Fgf4 with Tgfh-related
Activin and/or Nodal is sufficient to maintain TS cells in
a multipotent state (Erlebacher et al., 2004; Guzman-Ayala
et al., 2004; Tanaka et al., 1998). It is likely that a
combination of growth factors that act in vivo will be most
efficient in vitro to maintain stem cell progenitors in an
undifferentiated state.
A handful of transcription factors has been described as
essential for the establishment and/or maintenance of ES or
TS cells. As described previously, we have shown that
Foxd3 is required to maintain the epiblast of the mouse
embryo, and derivation of ES cells either de novo from
blastocysts or in vitro by retargeting Foxd3+/ ES cells is
not possible without Foxd3 protein (Hanna et al., 2002). In
ES cells, different levels of the Pou-containing homeobox
gene Pou5f1 encoding Oct4 can alter the fate of ICM
towards trophoblast or ICM (Nichols et al., 1998; Niwa et
al., 2000). The homeodomain protein Nanog is also required
in the ICM lineage, and null mutations in Nanog result in
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endoderm (Chambers et al., 2003; Mitsui et al., 2003). In
the case of the trophectoderm, TS cells require a different
group of transcription factors: Eomes, a T-box protein,
Cdx2, a homedomain protein and Errb, a nuclear hormone
receptor (Chawengsaksophak et al., 2004; Russ et al., 2000;
Tremblay et al., 2001).
In addition to Foxd3, there is one other transcription
factor thus far known to be required in both these
lineages: Sox2. Analysis of Sox2/ mutants suggests
that this protein might act upstream of Foxd3 because
Sox2/ embryos die earlier than Foxd3/ mutants and
chimeras generated by injection of wild type ES cells into
Sox2/ embryos did not survive past ¨7.5 dpc due to
extraembryonic defects (Avilion et al., 2003). In addition,
Sox2 mRNA is initially expressed in Foxd3/ blasto-
cysts (Hanna et al., 2002). The data presented here are
consistent with the idea that Foxd3 is required for
maintaining the stem cell pool in an undifferentiated state
downstream of Oct4 and Sox2 in ES cells and down-
stream of Eomes, Errb, Cdx2 and Sox2 in TS cells.
However, since Oct4, Fgf4 and Sox2 are normally
expressed in Foxd3/ blastocysts, and embryos with
null mutations in these genes die much earlier (appro-
ximately 1–2 days earlier) than Foxd3/ embryos, it is
doubtful that Foxd3 is directly downstream of these
proteins in the blastocyst.
Foxd3 is expressed in multipotent neural crest cells later
in embryogenesis, can specify neural crest fate and over-
expression of Foxd3 inhibits the differentiation of these
cells (Dottori et al., 2001; Labosky and Kaestner, 1998).
Similarly, Sox2 is expressed in undifferentiated regions of
the neural tube and overexpression of Sox2 inhibits differ-
entiation of neural progenitors (Graham et al., 2003). It is
therefore possible that these two transcription factors, or
other related Fox and Sox proteins, will have similar roles in
maintaining the stem cell nature of varied progenitor cells in
vivo and in vitro. We have additional evidence that Foxd3 is
expressed in cultured neural progenitor cells derived from
postnatal cerebellum, and in neural crest stem cells (NCSCs)
derived from the skin (SKP cells; Fernandes et al., 2004)
(Supplementary Fig. 1), so it is possible that Foxd3 may
play a similar maintenance role in other stem cell popu-
lations in the embryo and adult. The molecular mechanism
of Foxd3 function is not yet clear. The protein functions as a
transcriptional repressor in multiple contexts (Kos et al.,
2001; Sutton et al., 1996) and it is possible that it might
function via chromatin remodeling similar to Foxa proteins
(Cirillo et al., 2002). In addition, in vitro evidence suggests
that Foxd3 and Oct4 physically interact to regulate down-
stream gene expression (Guo et al., 2002). The ability to
dissect the inherent molecular requirements of the self-
renewal behavior of different stem and progenitor cells in
vitro will enhance our ability to manipulate their behavior
and open possibilities for future therapeutic use of these
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